Solid Biosciences (SLDB) Financials: Revenue & Earnings
SLDB$6.46+0.27 +4.28%
$692.14M
Market Cap
—
P/E
—
Forward P/E
—
Score
Solid Biosciences (SLDB) Financials: Revenue & Earnings
SLDB price $6.46 +0.27 +4.28%
- Ticker
- SLDB
- Price
- $6.46
- Change
- +0.27 +4.28%
- Market cap ?
- $692.14M
- Beta ?
- 2.47
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
SLDB fair value $21.37. Price $6.46. Price is 70% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.32M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 107.22M. Net debt -38.74M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-02 | — | -0.37 | — | — |
| 2026-08-06 | -0.38 | -0.46 | — | — |
| 2026-05-12 | -0.52 | -0.40 | — | — |
| 2026-03-19 | -0.50 | -0.51 | — | — |
| 2025-11-03 | -0.48 | -0.42 | — | — |
| 2025-08-12 | -0.42 | -0.51 | — | — |
| 2025-05-15 | -0.59 | -0.53 | — | — |
| 2025-03-06 | -0.89 | -0.79 | — | — |
| 2024-11-06 | -0.79 | -0.67 | — | — |
| 2024-08-13 | -0.61 | -0.68 | — | — |
| 2024-05-15 | -0.64 | -0.57 | — | 1.21M |
| 2024-03-13 | -1.00 | -1.01 | 4.74M | — |
| 2023-11-08 | -1.05 | -1.20 | — | 1.10M |
| 2023-08-14 | -1.25 | -1.52 | — | 1.47M |
| 2023-05-11 | -1.54 | -1.83 | — | 1.47M |
| 2023-03-23 | -0.68 | -2.70 | 8.09M | 1.17M |
| 2022-11-10 | -2.71 | -2.59 | — | 300.00K |
| 2022-08-11 | -3.30 | -3.15 | 6.17M | 4.08M |
| 2022-04-27 | -3.30 | -2.70 | 1.93M | 2.68M |
| 2022-03-14 | -2.55 | -3.00 | 3.15M | 1.73M |
| 2021-11-03 | -2.40 | -2.85 | 3.54M | 1.32M |
| 2021-08-16 | -2.55 | -2.70 | 3.59M | 1.32M |
| 2021-05-14 | -2.85 | -4.20 | 3.33M | 4.22M |
| 2021-03-15 | -4.65 | -5.10 | 98.32M | — |
| 2020-11-05 | -6.60 | -4.80 | — | — |
| 2020-08-06 | -5.85 | -6.00 | — | — |
| 2020-05-07 | -7.80 | -9.00 | — | — |
| 2020-03-12 | -10.04 | -8.40 | — | — |
| 2019-11-12 | -10.04 | -9.45 | — | — |
| 2019-08-14 | -11.39 | -10.79 | — | — |
| 2019-05-13 | -12.74 | -9.15 | — | — |
| 2019-03-13 | -10.04 | -8.70 | — | — |
| 2018-11-13 | -8.25 | -8.25 | — | — |
| 2018-08-10 | -7.80 | -7.80 | — | — |
| 2018-05-10 | -8.10 | -6.80 | — | — |
| 2018-03-29 | -13.35 | -8.95 | — | — |
| 2018-01-29 | -10.53 | — | — | — |
| 2017-06-30 | -8.82 | — | — | — |
| 2017-03-31 | -9.99 | — | — | — |
| 2016-12-31 | -6.05 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-19 | Brooks Gabriel | Sell | 4.37K | $5.62 | 24.58K |
| 2026-10-18 | Brooks Gabriel | Buy | 9.75K | — | — |
| 2026-10-18 | Brooks Gabriel | Sell | 9.75K | — | — |
| 2026-10-02 | SMITH IAN F | Buy | 3.44K | — | — |
| 2026-10-02 | SMITH IAN F | Sell | 3.44K | — | — |
| 2026-10-01 | Ganot Ilan | Buy | 150.00K | — | — |
| 2026-07-02 | SMITH IAN F | Buy | 3.44K | — | — |
| 2026-07-02 | SMITH IAN F | Sell | 3.44K | — | — |
| 2026-06-22 | RA CAPITAL MANAGEMENT, L.P. | Other | 0 | — | — |
| 2026-06-22 | RA CAPITAL MANAGEMENT, L.P. | Other | 0 | — | — |
| 2026-06-22 | RA CAPITAL MANAGEMENT, L.P. | Other | 0 | — | — |
| 2026-06-22 | RA CAPITAL MANAGEMENT, L.P. | Other | 8.18M | $0.00 | 8.18K |
| 2026-06-10 | Nagendran Sukumar | Buy | 77.50K | $6.61 | 512.27K |
| 2026-06-10 | SMITH IAN F | Buy | 77.50K | $6.61 | 512.27K |
| 2026-06-10 | Ganot Ilan | Buy | 77.50K | $6.61 | 512.27K |
| 2026-06-10 | PERCEPTIVE ADVISORS LLC | Buy | 77.50K | $6.61 | 512.27K |
| 2026-06-10 | Keresty Georgia | Buy | 77.50K | $6.61 | 512.27K |
| 2026-06-10 | Freed Martin I | Buy | 77.50K | $6.61 | 512.27K |
| 2026-06-10 | Kahn Clare | Buy | 77.50K | $6.61 | 512.27K |
| 2026-06-10 | Sullivan Lynne Marie | Buy | 77.50K | $6.61 | 512.27K |
| 2026-06-10 | Stone Adam Leo | Buy | 77.50K | $6.61 | 512.27K |
| 2026-04-02 | SMITH IAN F | Buy | 3.44K | — | — |
| 2026-04-02 | SMITH IAN F | Sell | 3.44K | — | — |
| 2026-03-09 | PERCEPTIVE ADVISORS LLC | Buy | 8.91M | $0.00 | 8.91K |
| 2026-02-18 | Cumbo Alexander | Sell | 16.64K | $5.82 | 96.92K |
| 2026-02-18 | Hanrahan Jessie | Sell | 4.13K | $5.82 | 24.07K |
| 2026-02-18 | Ganot Ilan | Sell | 2.66K | $5.82 | 15.48K |
| 2026-02-18 | Herzich Paul | Sell | 3.62K | $5.82 | 21.06K |
| 2026-02-18 | Howton David T | Sell | 7.47K | $5.82 | 43.49K |
| 2026-02-18 | Brooks Gabriel | Sell | 0 | $5.82 | 0 |
| 2026-02-18 | Tan Kevin | Sell | 5.40K | $5.82 | 31.47K |
| 2026-02-13 | Cumbo Alexander | Buy | 30.03K | — | — |
| 2026-02-13 | Cumbo Alexander | Sell | 30.03K | — | — |
| 2026-02-13 | Hanrahan Jessie | Buy | 8.12K | — | — |
| 2026-02-13 | Hanrahan Jessie | Sell | 8.12K | — | — |
| 2026-02-13 | Ganot Ilan | Buy | 4.86K | — | — |
| 2026-02-13 | Ganot Ilan | Sell | 4.86K | — | — |
| 2026-02-13 | Herzich Paul | Buy | 7.19K | — | — |
| 2026-02-13 | Herzich Paul | Sell | 7.19K | — | — |
| 2026-02-13 | Howton David T | Buy | 14.69K | — | — |
| 2026-02-13 | Howton David T | Sell | 14.69K | — | — |
| 2026-02-13 | Brooks Gabriel | Buy | 10.94K | — | — |
| 2026-02-13 | Brooks Gabriel | Sell | 10.94K | — | — |
| 2026-02-13 | Tan Kevin | Buy | 10.62K | — | — |
| 2026-02-13 | Tan Kevin | Sell | 10.62K | — | — |
| 2026-02-04 | Howton David T | Sell | 18.89K | $6.44 | 121.71K |
| 2026-02-04 | Cumbo Alexander | Sell | 48.91K | $6.44 | 315.09K |
| 2026-02-04 | Ganot Ilan | Sell | 7.21K | $6.44 | 46.41K |
| 2026-02-04 | Tan Kevin | Sell | 14.78K | $6.44 | 95.23K |
| 2026-02-04 | Brooks Gabriel | Sell | 12.62K | $6.44 | 81.27K |
| 2026-02-04 | Hanrahan Jessie | Sell | 12.35K | $6.44 | 79.54K |
| 2026-02-04 | Herzich Paul | Sell | 10.90K | $6.44 | 70.25K |
| 2026-02-02 | Tan Kevin | Sell | 26.84K | $6.44 | 172.75K |
| 2026-02-02 | Cumbo Alexander | Sell | 80.26K | $6.44 | 516.61K |
| 2026-02-02 | Hanrahan Jessie | Sell | 26.54K | $6.44 | 170.80K |
| 2026-02-02 | Brooks Gabriel | Sell | 28.34K | $6.44 | 182.39K |
| 2026-02-02 | Howton David T | Sell | 37.77K | $6.44 | 243.13K |
| 2026-02-02 | Herzich Paul | Sell | 26.25K | $6.44 | 168.97K |
| 2026-01-31 | Tan Kevin | Buy | 33.08K | — | — |
| 2026-01-31 | Tan Kevin | Sell | 33.08K | — | — |
| 2026-01-31 | Cumbo Alexander | Buy | 100.40K | — | — |
| 2026-01-31 | Cumbo Alexander | Sell | 100.40K | — | — |
| 2026-01-31 | Hanrahan Jessie | Buy | 27.62K | — | — |
| 2026-01-31 | Hanrahan Jessie | Sell | 27.62K | — | — |
| 2026-01-31 | Brooks Gabriel | Buy | 28.23K | — | — |
| 2026-01-31 | Brooks Gabriel | Sell | 28.23K | — | — |
| 2026-01-31 | Howton David T | Buy | 42.27K | — | — |
| 2026-01-31 | Howton David T | Sell | 42.27K | — | — |
| 2026-01-31 | Herzich Paul | Buy | 24.68K | — | — |
| 2026-01-31 | Herzich Paul | Sell | 24.68K | — | — |
| 2026-01-31 | Ganot Ilan | Sell | 15.00K | — | — |
| 2026-01-31 | Ganot Ilan | Buy | 15.00K | — | — |
| 2026-01-29 | Howton David T | Buy | 79.34K | — | — |
| 2026-01-29 | Brooks Gabriel | Buy | 58.85K | — | — |
| 2026-01-29 | Cumbo Alexander | Buy | 169.40K | — | — |
| 2026-01-29 | Herzich Paul | Buy | 54.92K | — | — |
| 2026-01-29 | Tan Kevin | Buy | 56.65K | — | — |
| 2026-01-29 | Hanrahan Jessie | Buy | 54.92K | — | — |
| 2026-01-29 | Tan Kevin | Buy | 187.00K | $6.60 | 1.23M |
| 2026-01-29 | Tan Kevin | Buy | 56.65K | — | — |
| 2026-01-29 | Tan Kevin | Buy | 93.50K | — | — |
| 2026-01-29 | Tan Kevin | Sell | 56.65K | — | — |
| 2026-01-29 | Cumbo Alexander | Buy | 509.85K | $6.60 | 3.37M |
| 2026-01-29 | Cumbo Alexander | Buy | 254.90K | — | — |
| 2026-01-29 | Cumbo Alexander | Buy | 169.40K | — | — |
| 2026-01-29 | Cumbo Alexander | Sell | 169.40K | — | — |
| 2026-01-29 | Hanrahan Jessie | Buy | 190.00K | $6.60 | 1.25M |
| 2026-01-29 | Hanrahan Jessie | Buy | 95.00K | — | — |
| 2026-01-29 | Hanrahan Jessie | Buy | 54.92K | — | — |
| 2026-01-29 | Hanrahan Jessie | Sell | 54.92K | — | — |
| 2026-01-29 | Brooks Gabriel | Buy | 207.45K | $6.60 | 1.37M |
| 2026-01-29 | Brooks Gabriel | Buy | 103.75K | — | — |
| 2026-01-29 | Brooks Gabriel | Buy | 58.85K | — | — |
| 2026-01-29 | Brooks Gabriel | Sell | 58.85K | — | — |
| 2026-01-29 | Howton David T | Buy | 210.20K | $6.60 | 1.39M |
| 2026-01-29 | Howton David T | Buy | 79.34K | — | — |
| 2026-01-29 | Howton David T | Buy | 105.10K | — | — |
| 2026-01-29 | Howton David T | Sell | 79.34K | — | — |
| 2026-01-29 | Herzich Paul | Buy | 170.00K | $6.60 | 1.12M |
| 2026-01-29 | Herzich Paul | Buy | 85.00K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 163, holders +14 vs prior quarter. Ownership 79.89%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 12.04M | 2.70M | +28.87% | 120.24M |
| PERCEPTIVE ADVISORS LLC | 11.91M | 0 | 0.00% | 118.95M |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 9.81M | 0 | 0.00% | 97.99M |
| SIREN, L.L.C. | 7.69M | 0 | 0.00% | 76.83M |
| BLACKROCK, INC. | 6.93M | 1.98M | +39.85% | 69.27M |
| FMR LLC | 6.88M | 3.27M | +90.66% | 68.69M |
| ARMISTICE CAPITAL, LLC | 4.28M | 1.08M | +33.69% | 42.74M |
| STATE STREET CORP | 4.18M | 3.05M | +270.98% | 41.71M |
| JUPITER TOPCO LLC | 4.04M | 4.04M | New | 40.38M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.01M | 1.34M | +49.92% | 40.06M |
| RTW INVESTMENTS, LP | 3.89M | 3.89M | New | 38.89M |
| DEEP TRACK CAPITAL, LP | 3.57M | 0 | 0.00% | 35.61M |
| FRANKLIN TEMPLETON INC | 3.44M | 1.25M | +56.90% | 34.37M |
| CITADEL ADVISORS LLC | 2.82M | 2.80M | +15035.06% | 28.12M |
| ALYESKA INVESTMENT GROUP, L.P. | 2.28M | 359 | +0.02% | 22.78M |
| AMERIPRISE FINANCIAL INC | 2.23M | -213.07K | -8.74% | 22.24M |
| VESTAL POINT CAPITAL, LP | 2.16M | -2.84M | -56.80% | 21.58M |
| REDMILE GROUP, LLC | 1.95M | -63.20K | -3.14% | 19.47M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.94M | 644.84K | +49.76% | 19.39M |
| GOLDMAN SACHS GROUP INC | 1.60M | 667.38K | +71.34% | 16.01M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.51M | -250.00K | -14.23% | 15.05M |
| DIMENSIONAL FUND ADVISORS LP | 1.27M | 310.15K | +32.44% | 12.65M |
| BLAIR WILLIAM & CO/IL | 756.28K | 105.06K | +16.13% | 7.56M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 748.59K | 409.96K | +121.06% | 7.48M |
| WOODLINE PARTNERS LP | 674.08K | 179.00K | +36.16% | 6.73M |
Earnings and financials
Solid Biosciences Inc. (SLDB) trades at $6.46, with a market cap of $692.14M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn